Marta Iozzo

Featured in: Favicon

nature.com Favicon

aacrjournals.org Favicon

onlinelibrary.wiley.com Favicon

cancerres.aacrjournals.org

Articles

Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer - Nature Communications

Aug 5, 2024 | nature.com | Dheeraj A. Shinde |Luca Guarrera |Marta Iozzo |Roger L. Geiger |Marco Bolis |Carlo V. Catapano | +2 more

AbstractCastration-resistant prostate cancer (CRPC) is a frequently occurring disease with adverse clinical outcomes and limited therapeutic options. Here, we identify methionine adenosyltransferase 2a (MAT2A) as a critical driver of the androgen-indifferent state in ERG fusion-positive CRPC. MAT2A is upregulated in CRPC and cooperates with ERG in promoting cell plasticity, stemness and tumorigenesis.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →